Rankings
▼
Calendar
VERA Q4 2025 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
VERA
Vera Therapeutics, Inc.
$3B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$1M
Operating Income
-$94M
Net Income
-$91M
EPS (Diluted)
$-1.39
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$70M
Free Cash Flow
-$70M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$735M
Total Liabilities
$130M
Stockholders' Equity
$605M
Cash & Equivalents
$355M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$1M
$0
—
Operating Income
-$94M
-$49M
-92.6%
Net Income
-$91M
-$43M
-109.8%
← FY 2025
All Quarters